Page last updated: 2024-10-20

taurine and Alkaptonuria

taurine has been researched along with Alkaptonuria in 2 studies

Alkaptonuria: An inborn error of amino acid metabolism resulting from a defect in the enzyme HOMOGENTISATE 1,2-DIOXYGENASE, an enzyme involved in the breakdown of PHENYLALANINE and TYROSINE. It is characterized by accumulation of HOMOGENTISIC ACID in the urine, OCHRONOSIS in various tissues, and ARTHRITIS.

Research Excerpts

ExcerptRelevanceReference
" This leads to the accumulation of homogentisic acid (HGA) and its oxidized/polymerized products in connective tissues, which in turn become characterized by the presence of melanin-like pigments (ochronosis)."3.76Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. ( Amato, L; Bernardini, G; Braconi, D; Cavallo, G; Laschi, M; Marcolongo, R; Millucci, L; Santucci, A; Spreafico, A, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spreafico, A2
Millucci, L2
Ghezzi, L1
Geminiani, M1
Braconi, D2
Amato, L2
Chellini, F1
Frediani, B1
Moretti, E1
Collodel, G1
Bernardini, G2
Santucci, A2
Laschi, M1
Marcolongo, R1
Cavallo, G1

Other Studies

2 other studies available for taurine and Alkaptonuria

ArticleYear
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria.
    Rheumatology (Oxford, England), 2013, Volume: 52, Issue:9

    Topics: Acetylcysteine; Alkaptonuria; Antioxidants; Ascorbic Acid; Cell Line; Chondrocytes; Cytokines; Human

2013
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis.
    Rheumatology (Oxford, England), 2010, Volume: 49, Issue:10

    Topics: Acetylcysteine; Alkaptonuria; Antioxidants; Ascorbic Acid; Cells, Cultured; Coumaric Acids; Homogent

2010